North China Pharmaceutical: Obtains Registration Certificate for Adenosine Cobamide Capsules

North China Pharmaceutical announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for adenosine cobalamin capsules. Adenosine cobalamin is mainly used for the prevention and treatment of vitamin B12 deficiency, supplementation when the demand for vitamin B12 increases and is not met through diet, and megaloblastic anemia, etc. The "Drug Registration Certificate" obtained by the company for adenosine cobalamin capsules this time proves that the product meets the basic requirements for bidding for centralized procurement, the pharmacological effects are equivalent to the original product, effectively supplementing the company's product pipeline in the field of blood and hematopoietic system medicines.